HK1140476A1 - Regulatory compounds for pigmentation - Google Patents

Regulatory compounds for pigmentation

Info

Publication number
HK1140476A1
HK1140476A1 HK10106777.4A HK10106777A HK1140476A1 HK 1140476 A1 HK1140476 A1 HK 1140476A1 HK 10106777 A HK10106777 A HK 10106777A HK 1140476 A1 HK1140476 A1 HK 1140476A1
Authority
HK
Hong Kong
Prior art keywords
pigmentation
regulatory compounds
regulatory
compounds
Prior art date
Application number
HK10106777.4A
Other languages
English (en)
Inventor
Peypoch Angel Messeguer
Montiel Antonio Ferrer
Puche Juan Cebrian
Domenech Nuria Alminana
Serraima Cristina Carreno
Original Assignee
Lipotec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipotec Sa filed Critical Lipotec Sa
Publication of HK1140476A1 publication Critical patent/HK1140476A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
HK10106777.4A 2007-06-15 2010-07-13 Regulatory compounds for pigmentation HK1140476A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200701663A ES2310142B1 (es) 2007-06-15 2007-06-15 Compuestos reguladores de la pigmentacion.
US3708508P 2008-03-17 2008-03-17
PCT/ES2008/000230 WO2008152159A2 (es) 2007-06-15 2008-04-11 Compuestos reguladores de la pigmentación

Publications (1)

Publication Number Publication Date
HK1140476A1 true HK1140476A1 (en) 2010-10-15

Family

ID=40084602

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10106777.4A HK1140476A1 (en) 2007-06-15 2010-07-13 Regulatory compounds for pigmentation

Country Status (12)

Country Link
US (2) USRE46228E1 (xx)
EP (1) EP2159223B1 (xx)
JP (1) JP5455897B2 (xx)
KR (1) KR101463286B1 (xx)
CN (1) CN101730689B (xx)
CL (1) CL2008001278A1 (xx)
ES (2) ES2310142B1 (xx)
HK (1) HK1140476A1 (xx)
MY (1) MY148437A (xx)
TW (1) TWI407976B (xx)
WO (1) WO2008152159A2 (xx)
ZA (1) ZA200908596B (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2316416B1 (de) 2009-10-28 2015-12-23 PM-International AG Hautaufhellende kosmetische Zusammensetzung
KR101688815B1 (ko) * 2010-08-13 2016-12-23 (주)아모레퍼시픽 프로판노이드 유도체를 함유하는 백모 방지용 및 백반증 치료용 조성물
JP6005397B2 (ja) * 2012-05-18 2016-10-12 株式会社コーセー 皮膚外用剤
CN102697702B (zh) * 2012-06-08 2013-04-17 钟春燕 一种美白保湿修复体膜及制备方法
CN102670480B (zh) * 2012-06-08 2013-05-22 钟春燕 一种控油保湿修复体膜及制备方法
DE102012222970A1 (de) * 2012-12-12 2014-06-12 Henkel Ag & Co. Kgaa Wirkstoffkombination zur Hautaufhellung I
EP2789369B1 (en) * 2013-04-14 2018-06-06 Symrise AG A composition for lightening skin and hair
US9226890B1 (en) 2013-12-10 2016-01-05 Englewood Lab, Llc Polysilicone base for scar treatment
DE102014211185A1 (de) * 2014-06-11 2015-12-17 Henkel Ag & Co. Kgaa Kosmetische Zusammensetzungen zur Hautaufhellung
WO2016014529A1 (en) * 2014-07-21 2016-01-28 Wisys Technology Foundation, Inc. Skin lightening compounds
US20160089319A1 (en) * 2014-09-29 2016-03-31 Elc Management Llc Actives for stimulating differentiation of keratinocytes to lighten hyperpigmented skin
US10905646B2 (en) 2014-10-31 2021-02-02 Lubrizol Advanced Materials, Inc. Thermoplastic polyurethane film for delivery of active agents to skin surfaces
JP6594661B2 (ja) * 2015-05-25 2019-10-23 月桂冠株式会社 新規染色剤原料の製造方法
FR3036617B1 (fr) * 2015-05-27 2018-08-31 L'oreal Derives (1-phenyl-2-phenyl) ethylene polyhydroxyles a titre d'agent anti-age et photoprotecteur
CA3003871A1 (en) 2015-11-05 2017-05-11 Lubrizol Advanced Materials, Inc. Thermoformable dual network hydrogel compositions
US10493020B2 (en) 2016-04-14 2019-12-03 The Procter & Gamble Company Method of improving the appearance of periorbital dyschromia
JP7171355B2 (ja) * 2018-10-05 2022-11-15 株式会社ナリス化粧品 メラニン分解促進剤
CN109971269B (zh) * 2019-04-08 2020-11-06 沈阳顺风新材料有限公司 一种环保疏水涂料
CN110123819B (zh) * 2019-06-03 2022-03-15 南阳南石医院 一种用于治疗疤痕的药物和装置
EP3785696A1 (en) * 2019-08-28 2021-03-03 B.R.A.I.N. Biotechnology Research And Information Network AG Cosmetic use of aromatic formamidine derivatives
US11400043B2 (en) * 2019-12-10 2022-08-02 Mary Kay Inc. Cosmetic composition
EP4164588A1 (en) * 2020-06-12 2023-04-19 Mary Kay, Inc. Topical compositions and methods
CN114073654A (zh) * 2020-08-21 2022-02-22 大江生医股份有限公司 露莓汁液用于制备调理肌肤的组合物的用途
CN116948961B (zh) * 2023-09-20 2023-11-24 内蒙古奕宏医学研究有限公司 一种白细胞提取物、抗皱紧致面霜及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52147433A (en) * 1976-06-02 1977-12-07 Fuji Photo Film Co Ltd Color photographic light sensitive material
US4162326A (en) * 1978-09-27 1979-07-24 Stauffer Chemical Company Insect control agents
ES2072223B1 (es) * 1993-11-25 1996-03-16 Lipotec Sa Liposomas encapsulando doxorubicina.
FR2775976B1 (fr) * 1998-03-10 2000-06-02 Fabre Pierre Dermo Cosmetique Composition pharmaceutique ou cosmetique contenant un precurseur d'actif hydrolysable par la glucocerebrosidase
ES2154560B1 (es) * 1998-09-16 2001-12-01 Lipotec Sa Composicion a base de derivados de cromanos y su uso para reducir quimicamente las reacciones oxidativas o inducidas por radicales libres.
JP3490658B2 (ja) 1999-04-19 2004-01-26 カネボウ株式会社 美白化粧料
EP1267813A2 (de) 2000-03-31 2003-01-02 Henkel Kommanditgesellschaft auf Aktien Verwendung von protease-inhibitoren in der kosmetik und pharmazie
FR2808189B1 (fr) * 2000-04-28 2004-03-05 Oreal Lipochroman-6 comme inhibiteur de no-synthase et utilisations
FR2811567B1 (fr) 2000-07-13 2003-01-17 Oreal Composition, notamment cosmetique, comprenant la dhea et/ou un precurseur ou derive de celle-ci, en association avec au moins un inhibiteur de no-synthase
FR2818136B1 (fr) 2000-12-15 2004-10-15 Oreal Composition, notamment cosmetique, comprenant la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins un inhibiteur de no-synthase
DE10063433A1 (de) 2000-12-20 2002-06-27 Henkel Kgaa Verwendung von DNA-Reparatur-Enzymen als MMP-1-Inhibitoren
FR2825088A1 (fr) * 2001-05-25 2002-11-29 Derma Dev Nouveaux esters de tocopherol, leurs procedes d'obtention et leurs utilisations
DE10206664A1 (de) 2002-02-15 2003-09-04 Henkel Kgaa 6,7-disubstituierte 2,2-Dialkylchromane oder- chromene als Entzündungshemmer
DE10259014A1 (de) 2002-12-16 2004-06-24 Henkel Kgaa Antioxidans-Kombinationen mit6,7-disubstituierten 2,2-Dialkylchromanen oder-chromenen
DE10260954A1 (de) 2002-12-20 2004-07-01 Henkel Kgaa Arylsulfatase-Inhibitoren in Deodorantien und Antitranspirantien
DE10260955A1 (de) 2002-12-20 2004-07-08 Henkel Kgaa Verwendung von Steroidsulfatase-Inhibitoren zur Verminderung von Haarausfall
DE202004012807U1 (de) 2004-08-13 2004-10-21 Henkel Kgaa Kosmetische und dermatologische Zusammensetzungen mit DNA-Reparaturenzymen und Oligopeptiden

Also Published As

Publication number Publication date
CN101730689B (zh) 2013-08-14
KR20100040857A (ko) 2010-04-21
USRE46228E1 (en) 2016-12-06
JP2010529978A (ja) 2010-09-02
US8110207B2 (en) 2012-02-07
ZA200908596B (en) 2011-03-30
CN101730689A (zh) 2010-06-09
TW200904481A (en) 2009-02-01
US20100247587A1 (en) 2010-09-30
CL2008001278A1 (es) 2009-04-17
EP2159223B1 (en) 2014-03-12
ES2310142B1 (es) 2009-12-04
TWI407976B (zh) 2013-09-11
KR101463286B1 (ko) 2014-11-27
WO2008152159A3 (es) 2009-01-29
EP2159223A2 (en) 2010-03-03
JP5455897B2 (ja) 2014-03-26
ES2310142A1 (es) 2008-12-16
MY148437A (en) 2013-04-30
ES2468368T3 (es) 2014-06-16
WO2008152159A2 (es) 2008-12-18

Similar Documents

Publication Publication Date Title
HK1140476A1 (en) Regulatory compounds for pigmentation
GB0706793D0 (en) Compounds
GB0709534D0 (en) Compounds
GB0704407D0 (en) Compounds
ZA200905738B (en) Iron-hydrocarbon complex compounds
GB0704394D0 (en) Compounds
GB0705672D0 (en) Compounds
GB0706173D0 (en) Compounds
GB0706165D0 (en) Compounds
GB0706168D0 (en) Compounds
GB0706174D0 (en) Compounds
GB0706167D0 (en) Compounds
GB0706164D0 (en) Compounds
GB0706170D0 (en) Compounds
GB0716632D0 (en) Compounds
GB0704939D0 (en) Compounds
GB0703756D0 (en) Compounds
GB0701985D0 (en) Compounds
GB0700286D0 (en) Compounds
GB0702960D0 (en) Compounds
GB0706023D0 (en) Compounds
GB0702863D0 (en) Compounds
GB0705330D0 (en) Compounds
GB0700287D0 (en) Compounds
GB0701197D0 (en) Compounds

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190409